Screening Guideline Development

Screening Guideline Development is the systematic process of creating evidence-based recommendations for the early detection of infectious cancers, distinguished from related guideline development activities by its specific focus on screening modalities, target populations, and risk stratification strategies tied to infection-related carcinogenesis.

104

Publications

7.3K

Citations

717

Authors

433

Institutions

Publications per year

2017–2026

49

Authors

717

  1. MS
    Mona Saraiya

    Centers for Disease Control and Prevention, United States

    3 publications · 212 citations

    3

    h-index

  2. JT
    Jinhui Tian

    Lanzhou University, China

    3 publications · 163 citations

    3

    h-index

  3. KR
    K. Robin Yabroff

    American Cancer Society, United States

    3 publications · 216 citations

    3

    h-index

  4. GY
    Gigi Yuan

    National Cancer Institute, United States

    2 publications · 191 citations

    2

    h-index

  5. AB
    Anthony B. Miller

    University of Toronto, Canada

    2 publications · 261 citations

    2

    h-index

1–5 of 717

Venues

  1. PubMed

    Repository · 10 publications · 371 citations

    10

    h-index

  2. BMJ

    4 publications · 574 citations

    4

    h-index

  3. PLoS ONE

    3 publications · 176 citations

    3

    h-index

  4. JNCI Journal of the National Cancer Institute

    3 publications · 58 citations

    3

    h-index

  5. Japanese Journal of Clinical Oncology

    JJCO · 2 publications · 153 citations

    2

    h-index

1–5